Healthcare provider profile · identity verified

Michael Gomendoza, MD

Internal Medicine · CORALVILLE, IA · NPI 1174637110

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	426	126
Atorvastatin Calcium	Atorvastatin Calcium	409	112
Amlodipine Besylate	Amlodipine Besylate	359	102
Levothyroxine Sodium	Levothyroxine Sodium	281	72
Omeprazole	Omeprazole	262	80
Metoprolol Succinate	Metoprolol Succinate	238	63
Lisinopril	Lisinopril	237	59
Losartan Potassium	Losartan Potassium	206	55
Allopurinol	Allopurinol	187	52
Tamsulosin Hcl	Tamsulosin Hcl	156	46
Gabapentin	Gabapentin	150	35
Pantoprazole Sodium	Pantoprazole Sodium	150	38
Albuterol Sulfate Hfa	Albuterol Sulfate	130	49
Jardiance	Empagliflozin	128	22
Alendronate Sodium	Alendronate Sodium	122	30
Metformin Hcl Er	Metformin Hcl	119	30
Metformin Hcl	Metformin Hcl	112	28
Ezetimibe	Ezetimibe	111	29
Hydrochlorothiazide	Hydrochlorothiazide	108	27
Montelukast Sodium	Montelukast Sodium	104	28
Escitalopram Oxalate	Escitalopram Oxalate	103	29
Famotidine	Famotidine	102	32
Trazodone Hcl	Trazodone Hcl	99	25
Metoprolol Tartrate	Metoprolol Tartrate	95	19
Furosemide	Furosemide	93	27
Glipizide	Glipizide	83	24
Potassium Chloride	Potassium Chloride	80	28
Finasteride	Finasteride	75	23
Duloxetine Hcl	Duloxetine Hcl	74	19
Clopidogrel	Clopidogrel Bisulfate	73	19
Pravastatin Sodium	Pravastatin Sodium	65	18
Olmesartan Medoxomil	Olmesartan Medoxomil	56	13
Tizanidine Hcl	Tizanidine Hcl	54	18
Sertraline Hcl	Sertraline Hcl	49	11
Azelastine Hcl	Azelastine Hcl	48	22
Simvastatin	Simvastatin	48	13
Mirtazapine	Mirtazapine	42	12
Tramadol Hcl	Tramadol Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	13
Carvedilol	Carvedilol	41	14
Fluticasone Propionate	Fluticasone Propionate	41	15
Pregabalin	Pregabalin	41	13
Synthroid	Levothyroxine Sodium	41	11
Bupropion Xl	Bupropion Hcl	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	39	27
Trulicity	Dulaglutide	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Atenolol	Atenolol	35	13
Alprazolam	Alprazolam	34	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	12
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	27
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Eliquis	Apixaban	30	11
Cephalexin	Cephalexin	29	16
Colchicine	Colchicine	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Prednisone	Prednisone	29	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	25	suppressed
Azithromycin	Azithromycin	25	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	12
Meloxicam	Meloxicam	25	11
Torsemide	Torsemide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Mupirocin	Mupirocin	23	15
Nifedipine Er	Nifedipine	23	suppressed
Lorazepam	Lorazepam	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Ozempic	Semaglutide	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Cefuroxime	Cefuroxime Axetil	15	14
Celecoxib	Celecoxib	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Savella	Milnacipran Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Folic Acid	Folic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error